文献速递免疫规划传染病防控与疫情报告

韩国疫苗株与流行野型腮腺炎病毒交叉中和研究

Cross-neutralization between vaccine and circulating wild-type mumps viruses in Korea.
PubMed 文献 · Vaccine · 2021-02-26

研究比较了韩国1998-2016年流行的F、H、I基因型腮腺炎野毒株与A基因型疫苗株的HN基因氨基酸序列,并检测了50名接种单剂MMR疫苗的1-2岁儿童的交叉中和抗体滴度。结果显示HN蛋白中和表位存在4-5个氨基酸差异,且接种后血清对F、H、I基因型的FRNT滴度显著低于A基因型。

要点

  • 韩国流行野毒株HN蛋白中和表位与A基因型疫苗株存在4-5个氨基酸差异。
  • 接种单剂MMR后对F、H、I基因型的FRNT中和滴度显著低于A基因型。
  • HN基因遗传保守程度可能影响疫苗接种人群的腮腺炎再发风险。

核心结论

  • 疫苗诱导的中和抗体对韩国流行F、H、I基因型腮腺炎病毒的交叉中和能力低于疫苗同源A基因型。

研究设计与样本

  • 选取韩国1998-2016年流行的F、H、I基因型野毒株,分析HN基因氨基酸序列。
  • 检测50名接种单剂MMR疫苗的1-2岁韩国儿童的腮腺炎病毒特异性IgG和FRNT滴度。

主要发现

  • HN蛋白序列分析显示糖基化位点无变化,但韩国分离株与A基因型疫苗株在中和表位存在4-5个氨基酸差异。
  • 接种后FRNT滴度对F、H、I基因型显著低于对A基因型。

临床怎么用

  • 提示应关注疫苗株与流行株的抗原匹配性,并评估加强免疫策略。

局限性

  • 仅检测50名儿童单剂MMR接种后的血清,样本量有限。
  • 未报告细胞免疫应答及长期保护效果数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Mumps is a contagious disease caused by the mumps virus. It can be prevented using mumps vaccines, administered as a measles-mumps-rubella (MMR) vaccine. For first and second dose immunization, children aged 12-15 months and 4-6 years have been administered this vaccine since 1997 in Korea. Nevertheless, mumps outbreaks still occur in vaccinated populations worldwide. Hence, immunity against these diseases may be attenuated, or there are antigenic differences between currently available vaccine strains and circulating wild-type viruses. After the introduction of national immunization programs in Korea, mumps cases became sporadic. Viral genotypes F, H, and I have emerged since 1998 whereas the vaccine strains belong to genotype A. Here, we compared the amino acid sequences of the haemagglutinin-neuraminidase (HN) gene from wild-type viruses and the mumps vaccine and measured the cross-neutralization titers between them. We selected the F, H, and I wild-type mumps strains circulating in Korea from 1998 to 2016 and analyzed changes in the amino acid sequence of the protein encoded by the HN gene. We measured mumps virus-specific IgG and rapid focus reduction neutralization test (FRNT) titers in Korean isolates and sera obtained from 50 children aged 1-2 years who had been administered a single dose of MMR vaccine. Analysis of the HN protein sequences disclosed no changes in the glycosylation sites but did reveal 4-5 differences between the Korean isolates and the genotype A vaccine strain in terms of the neutralizing epitope sites on their HN proteins. Post-vaccination FRNT titers were significantly lower against genotypes F, H, and I than they were against genotype A. This finding highlights the possibility of a recurrence of mumps outbreaks in vaccinated populations depending on the degree of genetic conservation of the HN gene. Further research into this issue is needed to prevent the resurgence of mumps.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Won H, Kim AR, Yoo JS, et al. Cross-neutralization between vaccine and circulating wild-type mumps viruses in Korea. Vaccine. 2021. PMID: 33642163. doi:10.1016/j.vaccine.2021.01.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。